ClinicalTrials.gg
Not yet recruitingNCT06882928UPPFR-KneeOAUpdated Mar 19, 2025

Applications of Ultrasound and Physical Parameters in Assessing Fall Risk in Patients With Knee Osteoarthritis

An observational study in Knee Osteoarthritis, Ultrasound Exams and Fall Risk, sponsored by National Taiwan University Clinical Trial Center. Not yet recruiting at 1 site in Taiwan. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2025-03-19.

Sponsored by National Taiwan University Clinical Trial Center · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
250
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 89 studies in Osteoarthritis, Knee with a site in Taiwan — 12 open to participants now, 14 under way, 3 of them phase 3. Osteoarthritis, Knee · Taiwan.

Started
2025
with 6 others
Observational
6 of 89
3 open now
Primary completion
2026-12
later than 6 of 13 live
Registered
79th of 89
by date

Among the 89 studies in Osteoarthritis, Knee with a site in Taiwan, this one is one of 7 that started in 2025, is one of 6 observational ones, reaches primary completion later than 6 of the 13 other live ones, and was the 79th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

12 of the 89 studies in Osteoarthritis, Knee with a site in Taiwan are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 89 studies in Osteoarthritis, Knee with a site in Taiwan, or all of them as a file.
02

Study summary

Falls are a significant issue for patients with knee osteoarthritis, as they can lead to hospitalization or even more severe consequences. Therefore, it is crucial to assess fall risk early in rehabilitation clinics. Sarcopenia, which is the reduction of muscle mass, increases the risk of falls. This study involved 250 adults with knee osteoarthritis, using a technology called POCUS to assess muscle mass, combined with other tests to track fall incidents over three months. The study is expected to find correlations between falls and factors like muscle mass and grip strength. This information can help doctors better predict which patients are at risk of falling and take preventive measures early. Future research will explore the effectiveness of different prevention strategies.

Read the detailed description

Background

Falls represent a significant health issue for patients with knee osteoarthritis, potentially leading to hospitalization, disability, or even death. Early screening for fall risk in rehabilitation clinics is crucial; however, challenges arise due to time constraints and individual differences among patients. Sarcopenia, characterized by a reduction in muscle mass, is closely associated with an increased risk of falls, and point-of-care ultrasound (POCUS) offers a non-invasive and effective tool for assessing muscle mass.

Methods

This prospective study involved 250 adults with knee osteoarthritis attending the orthopedic physical therapy outpatient department at National Taiwan University Hospital. POCUS technology was utilized to evaluate muscle mass, complemented by grip strength tests, lower limb strength assessments, self-reported fall risk questionnaires, sarcopenia assessments, get-up-and-go tests, thirty-second sit-to-stand tests, general nutrition screening for malnutrition, and bioimpedance analysis. A three-month follow-up study was conducted to monitor fall incidents.

Expected Results

During the three-month follow-up, it is anticipated that a certain proportion of participants will experience fall incidents. Significant correlations are expected to be identified between fall incidents and various measurements, including muscle mass assessed by POCUS, grip strength, lower limb strength, self-reported fall risk scores, sarcopenia assessments, get-up-and-go tests, thirty-second sit-to-stand tests, the geriatric nutritional risk index, and bioimpedance analysis. Differences between the fall group and the non-fall group on these variables will also be statistically significant, indicating that the combination of POCUS technology and other clinical assessment indicators enhances the predictive ability regarding fall risk in patients with knee osteoarthritis.

Future Clinical Applications

The integration of POCUS technology with other clinical assessment indicators may be applied in rehabilitation outpatient settings to screen for fall risk in adults with knee osteoarthritis, facilitating early intervention and prevention. Future research will investigate the effectiveness of various intervention strategies.

03

Conditions studied

  • Knee Osteoarthritis
  • Ultrasound Exams
  • Fall Risk
  • Sarcopenia in Elderly
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants eligible for the study include males and females aged 60 and above who are willing to sign an informed consent form, have a clinically confirmed diagnosis of knee osteoarthritis, have received at least one treatment in the outpatient rehabilitation department during the study period, and can walk independently, even with the use of assistive devices.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Males and females aged 60 and above, who are willing to sign an form.
  2. Participants must have a clinically confirmed diagnosis of knee osteoarthritis.
  3. Participants must have received at least one treatment in the outpatient rehabilitation department during the study period.
  4. Participants must be able to walk independently, even with the aid of assistive devices.

Exclusion criteria

Exclusion Criteria:

  1. Individuals who have undergone lower limb surgery or have significant lower limb deformities.
  2. Individuals with severe cognitive impairment who are unable to understand or comply with the study procedures.
  3. Individuals who cannot communicate in a language understandable by the research team.
  4. Individuals with severe comorbidities that affect assessment or treatment (e.g., unable to safely complete assessments or treatments).
  5. Individuals planning to undergo knee surgery during the study period.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
250 participants (estimated)
Target follow-up
3 Months
Patient registry
Yes

Groups and cohorts

  • knee osteoarthritis

    Males and females aged 60 and above must have a clinically confirmed diagnosis of knee osteoarthritis.

06

What researchers measure

Primary outcomes

  1. Fall Incident Tracking

    Participants will be monitored for fall incidents over a three-month period, and the accuracy of the model predictions will be analyzed.

    Time frame: Three-month period

Secondary outcomes

  1. Grip strength testing

    Measures the maximum strength of hand and forearm muscles using a hand dynamometer. It reflects overall muscle function and the ability to perform daily tasks. Results are reported in kilograms or pounds.

    Time frame: Baseline grip strength

  2. POCUS Assessment

    Point-of-care ultrasound is used to measure participants' muscle mass

    Time frame: Baseline POCUS Assessment

  3. Sarcopenia Risk Assessment Questionnaire (SARC-F)

    An assessment tool designed to determine the risk of sarcopenia in individuals. Scale: The SARC-F consists of five questions scored from 0 to 10, with higher scores indicating a greater risk of sarcopenia.

    Time frame: Baseline Sarcopenia Risk Assessment Questionnaire (SARC-F)

  4. Bioelectrical Impedance Analysis (BIA) Measurement

    Conduct bioelectrical impedance measurements to assess body composition, including fat mass and lean body mass. Unit of Measure: Results are typically presented in kilograms and percentage for fat mass and lean body mass.

    Time frame: Baseline BIA measurement

  5. Knee extension strength testing

    Assesses the strength of the quadriceps by measuring the force exerted during knee extension against resistance, helping evaluate functional mobility. Results can be quantified as force or estimated one-repetition maximum.

    Time frame: Baseline knee extension strength testing

  6. Timed Up and Go (TUG) Test

    Evaluates mobility and balance by timing how long it takes a participant to rise from a chair, walk three meters, turn, and sit down. Longer times suggest a higher fall risk, especially in older adults.

    Time frame: Baseline Timed Up and Go (TUG) Test

  7. 30-Second Sit-to-Stand Test

    Counts how many times a participant can stand from sitting in 30 seconds. It assesses lower body strength and endurance, with higher counts indicating better functional ability.

    Time frame: Baseline 30-Second Sit-to-Stand Test

  8. Falls Efficacy Scale-International (FES-I)

    A scale that measures the concern about falling during daily activities. Scale: The FES-I includes 16 items scored from 16 to 64, where higher scores indicate greater concern about falling.

    Time frame: Baseline Falls Efficacy Scale-International (FES-I)

  9. Body weight measurement

    Measure the body weight of participants using a calibrated scale. Unit of Measure: Kilograms or pounds.

    Time frame: Baseline body weight measurement

  10. Height Measurement

    Record the participant's height using a stadiometer. Unit of Measure: Meters or centimeters.

    Time frame: Baseline height measurement

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2025; primary completion for Dec 2026, 21 months later.

Of 179 non-industry observational studies under Osteoarthritis, Knee, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 21 months is below that.

Counting every sponsor, half of 220 studies reached it within 24 months; a quarter within 13 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 25, 2025
First posted
Mar 19, 2025
StartEst.
Mar 24, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Mar 19, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06882928
Lead sponsor
National Taiwan University Clinical Trial Center
Responsible party
National Taiwan University Clinical Trial Center (physical therapist, National Taiwan University Hospital) — Sponsor-investigator
First posted
Mar 19, 2025
Start date
Mar 24, 2025 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Mar 19, 2025

Study contacts

Chih-Chin Lai
Contact
b94408040@gmail.com
886-988630906

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion